M&R Capital Management Inc. Sells 1,170 Shares of CVS Health Co. (NYSE:CVS)

M&R Capital Management Inc. trimmed its position in shares of CVS Health Co. (NYSE:CVS – Get Rating) by 0.7% during the fourth quarter, HoldingsChannel reports. The fund owned 168,826 shares of the pharmacy operator’s stock after selling 1,170 shares during the quarter. CVS Health comprises 4.3% of M&R Capital Management Inc.’s holdings, making the stock its 4th biggest position. M&R Capital Management Inc.’s holdings in CVS Health were worth $15,733,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also made changes to their positions in CVS. Cantor Fitzgerald Investment Advisor L.P increased its stake in shares of CVS Health by 92.9% during the first quarter. Cantor Fitzgerald Investment Advisor L.P now owns 377,875 shares of the pharmacy operator’s stock worth $38,245,000 after acquiring an additional 181,966 shares during the period. United Bank increased its stake in shares of CVS Health by 7.2% during the first quarter. United Bank now owns 18,658 shares of the pharmacy operator’s stock worth $1,888,000 after acquiring an additional 1,260 shares during the period. Loomis Sayles & Co. L P increased its stake in shares of CVS Health by 4,063.8% during the first quarter. Loomis Sayles & Co. L P now owns 12,075 shares of the pharmacy operator’s stock worth $1,222,000 after acquiring an additional 11,785 shares during the period. Zions Bancorporation N.A. increased its stake in shares of CVS Health by 116.9% during the first quarter. Zions Bancorporation N.A. now owns 2,572 shares of the pharmacy operator’s stock worth $260,000 after acquiring an additional 1,386 shares during the period. Finally, Ergoteles LLC purchased a new stake in CVS Health during the first quarter worth about $1,551,000. 77.29% of the stock is currently owned by institutional investors and hedge funds.

CVS Health Trading Down 1.9 %

Shares of CVS traded down $1.46 on Friday, hitting $74.37. 16,807,803 shares of the stock traded hands, compared to its average volume of 9,656,588. The company has a quick ratio of 0.67, a current ratio of 0.94 and a debt-to-equity ratio of 0.71. The firm has a market capitalization of $95.50 billion, a P/E ratio of 23.84, a P/E/G ratio of 1.17 and a beta of 0.65. The stock’s 50 day moving average is $85.40 and its two-hundred day moving average is $93.04. CVS Health Co. has a 1 year low of $73.91 and a 1 year high of $109.69.

CVS Health (NYSE:CVS – Get Rating) last announced its quarterly earnings data on Wednesday, February 8th. The pharmacy operator reported $1.99 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.92 by $0.07. The business had revenue of $83.85 billion for the quarter, compared to the consensus estimate of $76.37 billion. CVS Health had a net margin of 1.29% and a return on equity of 15.75%. The company’s quarterly revenue was up 9.5% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.98 earnings per share. As a group, sell-side analysts predict that CVS Health Co. will post 8.84 earnings per share for the current year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, May 1st. Investors of record on Friday, April 21st will be given a dividend of $0.605 per share. This represents a $2.42 annualized dividend and a yield of 3.25%. The ex-dividend date of this dividend is Thursday, April 20th. CVS Health’s dividend payout ratio (DPR) is 77.56%.

Analyst Ratings Changes

A number of analysts recently commented on the stock. Raymond James decreased their price objective on shares of CVS Health from $115.00 to $110.00 and set an “outperform” rating on the stock in a report on Thursday, February 9th. Jefferies Financial Group boosted their price objective on shares of CVS Health from $130.00 to $143.00 and gave the stock a “buy” rating in a report on Thursday, February 9th. TheStreet raised shares of CVS Health from a “c+” rating to a “b” rating in a report on Friday, November 25th. Barclays decreased their price objective on shares of CVS Health from $118.00 to $110.00 and set an “overweight” rating on the stock in a report on Thursday, February 9th. Finally, Credit Suisse Group boosted their price objective on shares of CVS Health from $117.00 to $125.00 and gave the stock an “outperform” rating in a report on Monday, November 21st. Three equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. According to MarketBeat.com, CVS Health has a consensus rating of “Moderate Buy” and an average price target of $119.65.

CVS Health Company Profile

(Get Rating)

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Pharmacy Services, Retail or Long-Term Care, Health Care Benefits, and Corporate and Other. The Pharmacy Services segment focuses on the pharmacy benefit management solutions.